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ABSTRACT
Linear chromosomes are stabilized by telomeres,
but the presence of short dysfunctional telomeres
triggers cellular senescence in human somatic
tissues, thus contributing to ageing. Approximately
1% of the population inherits a chromosomally
integrated copy of human herpesvirus 6 (CI-HHV-
6), but the consequences of integration for the
virus and for the telomere with the insertion are
unknown. Here we show that the telomere on the
distal end of the integrated virus is frequently
the shortest measured in somatic cells but not the
germline. The telomere carrying the CI-HHV-6 is
also prone to truncations that result in the formation
of a short telomere at a novel location within
the viral genome. We detected extra-chromosomal
circular HHV-6 molecules, some surprisingly
comprising the entire viral genome with a single
fully reconstituted direct repeat region (DR) with
both terminal cleavage and packaging elements
(PAC1 and PAC2). Truncated CI-HHV-6 and extra-
chromosomal circular molecules are likely recipro-
cal products that arise through excision of a
telomere-loop (t-loop) formed within the CI-HHV-6
genome. In summary, we show that the CI-HHV-6
genome disrupts stability of the associated
telomere and this facilitates the release of viral
sequences as circular molecules, some of which
have the potential to become fully functioning
viruses.
INTRODUCTION
The ends of linear chromosomes are distinguished from
double-strand breaks within the genome by specialized
nucleoprotein structures known as telomeres. Human telo-
meres comprise a variable-length double-stranded DNA
molecule that is predominantly 50-(TTAGGG)n-30 (1)
but includes, at the start of the repeat array, sequence-
variant or degenerate repeats interspersed with TTAGG
G repeats (2–4). Each telomere is terminated by an essen-
tial single-strand overhang of 50–300 nt (5). The telomeric
DNA binds to the six-protein complex, known as
Shelterin, via the double-strand binding TRF1 and
TRF2 proteins and the single-strand binding protein
POT1 (6). Telomeric DNA bound to the Shelterin
complex forms looped structures (t-loops) in which the
single-strand overhang invades the upstream duplex telo-
meric DNA forming a D-loop (7). The Shelterin complex
on the capped telomere prevents inappropriate repair by
non-homologous end-joining or by homologous recom-
bination (HR) (8) and, in conjunction with other protein
complexes, it regulates telomerase activity by controlling
access to the single-strand overhang. However, telomerase
is inactive in differentiated human cells and shows limited
activity in stem cells; consequently in most cells, telomeric
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DNA is eroded as a result of incomplete lagging-strand
synthesis and end-processing that restores single-strand
overhangs (6). Disturbance of the telomere capping
function or telomere length regulation can result in
genome instability leading to tumourigenesis, and the
presence of a few short telomeres (9,10) induces senes-
cence, which has known roles in ageing.
HHV-6A and B belong to the Roseolovirus genus of the
b-herpesvirus subfamily, and though closely related, they
present diverse biological, epidemiological, pathological
and molecular properties. HHV-6B is prevalent in most
populations and primary infection usually occurs in early
childhood (<2 years) causing an intense fever and rash,
whereas infections by HHV-6A tend to be less common
(11–13). As for most herpesviruses, HHV-6A and B can
remain latent lifelong, with the potential to reactivate that
can have severe consequences. For example, HHV-6B
reactivation in immunocompromised transplant patients
can cause encephalitis and has been linked to bone
marrow suppression and to graft failure (14). The HHV-
6A and B genomes are double-stranded DNA molecules
comprising 145 kb of unique sequence encoding U1 to
U100 ORFs, ﬂanked by identical left and right direct
repeats (DRL and DRR), each 8 kb (15–17). Each DR
is terminated by the packaging and cleavage sequences,
PAC1 and 2 (18), and includes two arrays of telomere-
like repeats (T1 and T2) and a variety of ORFs
(DR1–8). T2 is known to be a short array of pure (TTA
GGG)n that varies in length between viral isolates,
whereas T1 comprises an array of degenerate telomere-
like repeats (19,20).
HHV-6A and B are distinct among herpesviruses,
as they can integrate into the human telomeric DNA,
probably via HR with the terminal T2 region of DRR
(21–25). Once integrated in the germline, the
chromosomally integrated virus (CI-HHV-6) can be
inherited. Approximately 0.8% of the UK population
are CI-HHV-6 carriers (26), but it is not known whether
integration is a natural biological form of HHV-6 latency
or whether it affects normal telomere function and length
regulation. We show that the telomere carrying the
integrated virus is often the shortest measured and that
the presence of the full-length viral genome disrupts
stability of the telomere, resulting in frequent truncations.
Moreover, we detected extra-chromosomal circular DNA
comprising viral sequences and showed that the viral
genome can be released from the telomere, possibly via a
t-loop excision mechanism. Altogether, our data are con-
sistent with the proposal that telomeric integration is a
form of HHV-6 latency.
MATERIALS AND METHODS
Oligonucleotides
Oligonucleotides for ampliﬁcation of HHV6 sequences
were primarily designed based on the GenBank consensus
sequences for HHV-6A (U1102 accession no. X83413.1)
or HHV-6B (HST accession no. AB021506.1; Z29 acces-
sion no. AF157706.1).
DNA samples and lymphoblastoid cell lines
To identify CI-HHV-6 carriers, we screened the HapMap
Phase I (27), the CEPH-HGDP (28) and parental DNA
samples from the CEPH family panel (29). Therefore, we
screened 1178 samples from unrelated donors in these
three panels (duplicated samples between the panels were
removed). We also screened 528 samples in the People of
the British Isles panel (30) and 2153 samples from the
Orkney Complex Disease Study (31). The panel of 92
sperm donors, a gift from Alec J. Jeffreys (32), was also
screened for the presence of CI-HHV-6.
Lymphoblastoid cell lines (LCLs) from one CI-HHV-
6A (designated 3-10q26.3) and ﬁve CI-HHV-6B carriers
(designated 1-9q34.3, 2-9q34.3, 4-11p15.5, 5-17p13.3 and
6-17p13.3) reported previously (24) were donated by
Duncan Clark. Other LCLs were from Bruce Winney:
NWA090 (CI-HHV-6A), BAN519, COR264, CUM082,
DER512, NWA008, YOR546 (all CI-HHV-6B); from
David Gurwitz CEPH-HGDP00628 (CI-HHV6A); from
the cell bank at the Coriell Institute for Medical
Research: GM18999 (CI-HHV-6A), GM07022 (CI-
HHV-6B), CEPH 1375.02 [also known as GM10863 (CI-
HHV-6B)] and from other members of the CEPH 1375
family. All the LCLs were grown in RPMI1640 medium
with 10–15% foetal calf serum at 37C in a humidiﬁed
incubator with 5% CO2 and subcultured using standard
methods. To measure the telomere shortening rate in
the GM18999 (CI-HHV-6A) and CEPH1375.02 (CI-
HHV-6B) cell lines, the cells were cultured over a longer
period. The number of population doublings was
calculated from cell counts obtained using a haemocytom-
eter, and the percentage of dead cells was determined
using Trypan blue staining at each subculturing. Cell
pellets were obtained throughout the time course.
Identiﬁcation of HHV-6-positive DNA samples
Panels of DNA samples in 96-well format were screened by
polymerase chain reaction (PCR) for the presence of U11
or U18 sequences. Standard 10ml PCRs were prepared con-
taining 5ng genomic DNA, 0.3mM of each primer, 0.05U/
ml of Taq polymerase (Kapa Biosystems) and a buffer
supplied with the enzyme. Thermal cycling conditions
were 96C for 1min then 35 cycles of 96C for 15 s; 62–
64C for 30 s; and 68C for 1min). Forward and reverse
primers: U11F 50-TTTTTACATCACGACGCGATC;
U11R 50-GGGACGCGAATCGGAGGAAGC; U18F 50-
CATATCTGATCAACCTTGCGATG; and U18R 50-AT
AACAGCATCGTAAATGCACCC. Identiﬁcation of the
virus type was achieved by ampliﬁcation with primers
DR5F(A): 50-CGTCGACTTCTCGTTCTTTATGC;
DR5R(A): 50-CACATACCATGAACGGACACAC for
HHV-6A and DR7F(B): 50-AGGCG; DR7R(B): 50-CCG
AATACGTCCAATGTCCT for HHV-6B. Amplicons
of the expected sizes were detected by agarose gel
electrophoresis.
Single telomere length analysis
Single telomere length analysis (STELA) was conducted as
described (33) using the specialized PCR buffer and other
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modiﬁcations reported previously (34,35). The primer
concentrations in the 10 ml STELA reactions were
ﬂanking primer 0.3 mM, Telorette2 0.225 mM and Teltail
0.05 mM. The Taq polymerase (Kapa Biosystems) was
used at 0.04U/ml and Pwo (Genaxxon Bioscience) at
0.025U/ml. The primers located adjacent to the telomere
repeat and used to amplify the double-stranded portion of
the 12q, 17 p and XpYp telomeres were 12q-STELA: 50-C
GAAGCAGCATTCTCCTCAG; 17p6: 50-GGCTGAAC
TATAGCCTCTGC; XpYpE2: 50-TTGTCTCAGGGTC
CTAGTG. Primers used for STELA from the integrated
HHV-6A or B were DR1R: 50-GAAGAAGATGCGGTT
GTCTTGTT, DR3R: 50- GAACGTGGCCGTTACAGT
TTC, DR8R(HHV-6A): 50-GGATTACGGAGGTGAAT
GTTGC and DR8R(HHV-6B): 50-CGCCCGCGACTGC
CATAGAG. Control primers in the opposite orientation
that did not yield STELA amplicons were: DR1F: 50-ACC
TTGGCCCGAGCAAGAATGC, DR3F: 50- TCCGTTC
CCTCATCGGCATCT and DR8F: 50-CATAGATCGG
GACTGCTTGAA. The DNA in each STELA reaction
ranged between 100 and 1000 pg. Agarose gels (0.8%)
were used for telomere length analysis with size markers
(GeneRuler 1 kb and GeneRuler High Range DNA
ladder, Fermentas) run in every gel. Amplicon length
analysis was conducted on the phosphor-images
(minimum two gels per sample) using the Imagequant
software (Typhoon 9400, GE Healthcare). The length of
the ﬂanking DNA was subtracted from each amplicon,
and the median telomere length and interquartile range
of the telomere molecules were determined. For each
donor, the data from four telomeres are presented as
scatter plots (GraphPad Prism; GraphPad Software Inc.,
CA, USA). A random sample of blots was selected for
independent reanalysis. Within each donor, the median
length of the four measured telomeres was ranked to
identify the shortest. To determine which telomere was
most frequently the shortest across the donors, the
shortest telomere in each donor was assigned a value of
1 and the other three telomeres given a value of 0. In
donors where the difference between the two shortest telo-
meres was <100 bp, a value of 0.5 was assigned to each.
The shortest telomere frequencies were compared using
the non-parametric Kruskal–Wallis analysis (GraphPad
Prism), and if P< 0.05, the Dunn’s multiple comparison
test was used to compare speciﬁc telomeres.
Sequence analysis
Single STELA products were reampliﬁed, gel puriﬁed and
sequenced by the Sanger dideoxy termination method
using DR1R, DR392R 50-CCAGATGCGAGGAT
KAGTG; DR421R 50-GAGKGGTTGAAAGAGGGGT
AG or Teltail. Other PCR products were either sequenced
directly or, if necessary, reampliﬁed, gel puriﬁed and then
sequenced.
Isolation and characterization of chromosomal-HHV-6
junctions
The 10q-CI-HHV-6A junction fragment was isolated by
inverse PCR using the primers IPCR-1 and IPCR-2 (25).
The isolated DNA fragment was sequenced. The primer
10qF: 50-ATCCTTCCTCTTTGCAGCCG designed from
the sequence was used with the DR8F(A): 50-GCAGAGA
CAAAAGTATGCGGAAG primer to verify ampliﬁca-
tion of the 10q-CI-HHV-6A junction from genomic
DNA in this CI-HHV-6A carrier. The other four chromo-
some-CI-HHV-6-junction fragments were ampliﬁed with a
primer designed from the 17 p subtelomeric sequences
(36). The primer SubT17-539: 50- CCCAATTTACTGGT
AATGGACT anneals to subtelomeric DNA sequences on
several chromosomes, and it was used with the DR8F
primer to isolate junction fragments from one
CI-HHV6A and three CI-HHV-6B carriers. The isolated
amplicons were sequenced.
Sperm DNA analysis
The panel of sperm donors (32) was screened for the
presence of HHV-6 as described. There was sufﬁcient
DNA to conduct telomere length analysis by STELA
on one CI-HHV-6A and three CI-HHV-6B carriers.
Telomere length measurements in the sperm DNA
samples were made from phosphor-images of STELA
blots and scatter plots produced (as above). Frequency
histograms were generated by sizing individual molecules
and allocating them to 1 kb bins. Distributions were then
ﬁtted using a model with either one or two Gaussian dis-
tributions (GraphPad Prism). For single Gaussian distri-
butions, outliers were then deﬁned as those telomere
lengths of greater or less than three standard deviations
from the mean (which includes >99.7% of values from
that population). Where the data showed two Gaussian
distributions, the distribution of the major population was
used to determine the number of outliers. The frequency
of short outliers was then determined as a percentage of
the total number of telomere molecules analysed and
plotted against the mean telomere length. The data were
tested for linear correlation using Pearson’s correlation
coefﬁcient (GraphPad Prism).
Analysis of the HHV-6 DR regions
The length of the DRL-T2 was determined following PCR
using primers UDL6R: 50-TTTCGCTCACGTGGCAGT
CT and DR8F. The presence of PAC2 in these amplicons
was determined by PCR with UDL6R and a primer that
anneals to PAC2, PAC2F: 50-TGGGAGGCGCCGTGTT
TTTC. The absence of the PAC1 sequence in STELA
products (encompassing part of DRL-T1 and the
telomere) was determined by sequencing reampliﬁed gel-
puriﬁed products using primers DR1R, DR392R,
DR421R or Teltail. The length of the DRR-T1 region
was determined by PCR ampliﬁcation between U100F2:
50-TATCTCCGAACATGATGCTG and DR1R, and the
presence of DRR-PAC1 was determined by secondary
PCR with U100F2 and PAC1RB 50-CGGGGAGTTTA
AAGTAATTTTTG. The presence or absence of PAC1
was conﬁrmed by digestion of STELA products (DRL)
or U100F2-DR1R amplicons (DRR) with SmaI (cuts at
PAC1) or SalI as a control for digestion.
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Sequencing the CI-HHV-6B genome using ion
semiconductor technology
Overlapping amplicons across the unique region of HHV6
and the DRs (without T1 and T2) were generated from
CEPH1375.02 CI-HHV-6B carrier, using primers based
on the HST sequence (AB021506.1) (37). The amplicons
were pooled and sonicated using a Bioruptor (Diagenode
Inc.). The subsequent preparation of the sonicated DNA
for sequence analysis using an IonTorrent personal
genome sequencer (Life Technologies) was essentially con-
ducted according to the manufacturer’s protocol. Brieﬂy,
the sheared DNA was end repaired and the adapters were
ligated (according to Life Technologies’ protocol). Size
selection of 170 bp fragment was achieved in a 2.5%
NuSieve agarose gel followed by puriﬁcation using a
Zymoclean Gel DNA recovery kit (ZymoResearch,
Irvine, CA, USA). The size-selected DNA was then
prepared for Ion Torrent sequencing on a 314 chip
(100 bp read length) according to Life Technologies’
protocol.
Detection of HHV-6 RNA transcripts
Total RNA was extracted using Tri-reagent (Sigma-
Aldrich). The RNA was dissolved in water (100ml) and
treated with RNase-free DNase I (100U/ml, 20min,
37C). The RNA was puriﬁed by phenol–chloroform ex-
traction, precipitated with isopropanol and re-suspended
in RNase-free water (100ml). cDNA was synthesized from
2 mg of total RNA using M-MuLV reverse transcriptase
(10 u/ml, New England Biolabs) and random primer
hexamers (0.2 mM) in a total reaction volume of 20 ml at
42C for 1 h, followed by enzyme inactivation at 90C for
10min. PCRs were then performed in 10 ml, containing
40 ng of synthesized cDNA and 0.05U/ml of Taq DNA
polymerase. Oligonucleotides used were U38F: 5’-TTGT
AATTCTGCGCCGTTATC and U38R: 5’-TGCTGGTC
CTTCGACATAGA; U73F: 5’-TTACGGAGCGGCAG
ATAAAC and U73R: 5’-TGATGAGGGCGATTTGAG
TA; U90B2F: 5’-CCTGTTTCATGGCAGCCTTC and
U90B2R: 5’-ACGACATCGCTTCCAAGAATG for
HHV6B or U90A2R: 5’-CCTTCGATGACCTGATTAT
TCCA for HHV6A; U94-2F: 5’-AGACAGCCATTCGA
TGGTTC and U94-1R: 5’-TGGTACGCTCAAGCGGA
GAA. Thermal cycling conditions were denaturation at
96C for 1min followed by 35 cycles at 96C for 15 s,
annealing at 58–64C (depending on amplicons) for 20 s,
extension at 70C for 1min and a ﬁnal extension step at
70C for 10min. PCR products were analysed by agarose
gel (1%) electrophoresis.
2D gel analysis
Genomic DNA (25mg) from LCLs was digested with
100U of EcoRI in a 200-ml reaction volume at 37C for
2 h, extracted with phenol–chloroform and precipitated
with sodium acetate and ethanol. To enrich for circular
molecules, the EcoRI-digested genomic DNA was then
digested with 100U of ‘Plasmid-safe’ ATP-dependent
DNase (Epicentre), which only digests double-stranded
linear DNA, in a total volume of 500 ml at 37C for
20 h. The DNA was then concentrated by isopropanol
precipitation before 2D gel electrophoresis. Brieﬂy, the
DNA was separated in 0.4% agarose, 0.5 Tris-borate-
ethylenediaminetetraacetic acid buffer, pH 8.3, at 1V/cm
for 18 h at 4C in the ﬁrst dimension and in 1% HGT
agarose in 0.5Tris-borate-ethylenediaminetetraacetic
acid containing 0.5mg/ml ethidium bromide at 5V/cm
for 5.5 h in the second dimension. A Southern blot was
prepared and hybridized to a 32P-labelled HHV6B DR
probe, then after stripping to a telomere probe.
Detection of CI-HHV-6B truncations at DRL-T2
Genomic DNA (0.5 mg) was digested with ExoI (New
England Biolabs) to remove 30 single-strand overhangs
from telomeres. Following ExoI digestion, the integrity
of the double-stranded genomic DNA was veriﬁed by
PCR ampliﬁcation of 6 kb fragment using primers
U100FB 5’-CATCTGATCGTCATTTGGCG and
DR1R. STELA was conducted as above using ﬂanking
primers DR1R or the UDL6R on genomic DNA with
or without ExoI digestion.
Detection of extra-chromosomal circular HHV-6 DNA
Genomic DNA (90 ng/reaction) was ampliﬁed with
primers UDL6R and U100F at 0.2 mM with Taq (0.04U/
ml) and Pwo (0.025U/ml) DNA polymerases in 10 ml
reaction prepared in the same PCR buffer used for
STELA. Control PCRs were also performed with
primers UDL6R and DR3F or U100F2 and DR3R. The
PCR products were resolved in 0.8% agarose gels, and
Southern blots were prepared and hybridized to a DR3
probe generated using DR3F and DR3R primers. The
amplicons generated from extra-chromosomal circular
DNA in ﬁve separate PCRs from CEPH1375.11
CI-HHV-6B were reampliﬁed and the composition of
the DR region was veriﬁed by secondary PCRs and
sequencing.
RESULTS
Identiﬁcation of CI-HHV-6 carriers and veriﬁcation of
viral integration using STELA
To determine whether HHV-6 integration is a natural
biological form of latency and what effect it has on the
associated telomere, we investigated six LCLs from unre-
lated CI-HHV-6 carriers (24) with integration sites as
follows: one CI-HHV-6A at 10q, two CI-HHV-6B at
9q, one CI-HHV-6B at 11 p and two CI-HHV-6B at 17 p
(24). We used STELA (33) to conﬁrm integration and to
orientate the viral genome within the telomere (Figure 1A
and B).
To identify more CI-HHV-6 carriers, we screened 3859
DNA samples from unrelated donors (see Materials and
Methods) using primers that amplify conserved segments
from the viral U11 and U18 genes. Integration was veriﬁed
using STELA. As a result, 58 additional CI-HHV-6
positive samples were identiﬁed among the various
populations (4 CI-HHV-6A and 54 CI-HHV-6B).
Where available we obtained LCLs or additional high
4 Nucleic Acids Research, 2013
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Figure 1. Characterization of CI-HHV-6 carriers and proof of telomeric integration using STELA. (A) The HHV-6A or 6B genome inserts in the
reverse orientation such that DRR and the U100 gene are closest to the subtelomeric sequences. The DRL is expanded to show the reverse order of
DR8, 3 and 1 ORFs. Plain arrows represent primers. The telorette 2 oligonucleotide (grey line) and Teltail primer used in STELA are shown.
Orientation of DRs is shown by dashed arrows. Cen, centromere. (B) Ampliﬁcation of the CI-HHV-6-associated telomere using STELA in a CI-
HHV-6B carrier [1-9p34.3 (24)]. Amplicons are generated with the DR1, 3 and 8 reverse (R) primers but not the forward (F) primers, conﬁrming the
orientation of the integrated virus. The increasing size of the STELA products generated by DR1R, 3R and 8R reﬂects the distance from the 30
single-strand overhang. The blot was hybridized to a telomere probe. (C–E) Identiﬁcation of the CEPH1375 family that segregates CI-HHV-6B
through three generations. (C) Family members were screened for the presence the HHV-6 U18 gene. An amplicon from the XpYp telomere-adjacent
sequence was used as a PCR control. (D) CEPH1375 family members are positive for CI-HHV-6B and showed the presence of the HHV-6B DR7
and absence of the HHV-6A DR5. , size marker; NC, negative control. (E) CEPH1375 family showing transmission of CI-HHV-6B through three
generations. (F) Detection of STELA amplicons using the DR1R (R), but not the DR1F (F), primer conﬁrmed the orientation and integration of
HHV-6B in family members. All the STELA amplicons contain viral sequences (left) and (TTAGGG)n repeats (right). The maternal grandfather
(CEPH1375.11) shows particularly short telomeres on the end of the CI-HHV-6B.
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molecular weight genomic DNA from the newly identiﬁed
CI-HHV-6 carriers for further analysis. We also identiﬁed a
family (CEPH 1375) that has transmitted CI-HHV-6B over
three generations (Figure 1C–F).
Characterization of the DRs in CI-HHV6 carriers
Sequence analysis of single STELA products from seven
individuals showed that the terminal PAC1 sequence (at
the distal end of DRL) was absent in CI-HHV-6A (n=2;
3-10q26.3 and 1501) and CI-HHV-6B (n=5; 1-9q34.3,
2-9q34.3, 5-17p13.3, 6-17p13.3 and HGDP0092) carriers.
We isolated the 10q chromosome-HHV-6 junction from
one CI-HHV-6A carrier [3-10q26.3 (24)] using inverse
PCR (25). The internal chromosome-HHV-6 junctions
from four other carriers were isolated by ampliﬁcation
between a subterminal sequence (found at several chromo-
some ends, Sub17p-539) and the DR8F primer in DRR
(Figure 2 and Supplementary Figure S1). The isolated
chromosome-HHV-6 junctions all lacked the terminal
PAC2 sequence and showed a similar organization with
a short subterminal sequence, TTAGGG and sequence-
variant repeats commonly found in human telomeres (3)
followed by more (TTAGGG)n repeats of viral or human
origin and the DR8 sequence. In summary, the two
CI-HHV-6A junction fragments (from 3-10q26.3 and
HGDP0628) and two of the three CI-HHV-6B junction
sequences (from 1-9q34.3 and HGDP1065/HGDP1077)
are different from one another (GenBank Accession
Numbers: KF366418, KF366419, KF366420). The two
Sardinian CI-HHV-6B carriers (HGDP1065 and
HGDP1077) carried identical junctions suggesting
common ancestry.
Further characterization of the left and right DR regions
in 15 CI-HHV-6 carriers using a variety of primers (some
anchored in the unique region to facilitate speciﬁc ampliﬁ-
cation of DRR or DRL) conﬁrmed that the sequence organ-
ization is the same between the DRs. The length of the T2
region (perfect (TTAGGG)n) in DRL is variable between
carriers (20). Unexpectedly, the T1 region (degenerate
telomere-like repeats) in DRR is highly expanded
compared with the published strains (HHV-6A U1102;
HHV-6B HST and Z29) ranging between 0.7 and 1.5 kb
in CI-HHV-6A carriers and more strikingly 3–9 kb in
CI-HHV-6B carriers (Figure 2C). We also show that all
CI-HHV-6 carriers retain a copy of the PAC2 sequence
immediately adjacent to DRL-T2 and an internal copy
of PAC1 immediately distal to DRR-T1 (Figure 2C and
Supplementary Figure S2).
The CI-HHV6 telomere was often the shortest
measured in carriers
To investigate the length of the telomere on the end of the
virus, we used STELA with the DR1R primer to amplify
telomere molecules from small aliquots of LCL-DNA from
CI-HHV-6 carriers (Figure 3A). The median length of the
virus-associated telomere was compared with the length of
XpYp, 12q and 17p telomeres. In 50% (8/16) of the LCLs,
the CI-HHV-6-associated telomere was the shortest
measured (Figure 3B, Supplementary Figure S3A) (9,38),
even compared with the 17p telomere that has
been reported as often being the shortest (36,39).
Corresponding analysis of blood DNA samples from 24
carriers (21 CI-HHV-6B from the Orkney Complex
Disease Study study, and 3 CI-HHV-6A siblings in a
British family) again showed that the virus-associated
telomere was most often the shortest [42% (10/24);
Figure 3B and Supplementary Figure S3B], indicating
that short virus-associated telomeres do not arise from
the establishment or propagation of LCLs. The combined
data show that the shortest-telomere frequency differs sig-
niﬁcantly between the chromosome-ends in somatic cells
(Kruskal–Wallis test P< 0.0117) and is highest at the CI-
HHV-6-associated telomere (shortest in 45% of the
carriers).
CI-HHV-6-associated telomeres in the germline
To investigate virus-associated telomere lengths in the
germline, we screened sperm DNA samples from 92 men
from UK of North European descent (32) and identiﬁed
ﬁve (5.4%) CI-HHV-6 carriers (4 HHV-6B and 1 HHV-
6A), a higher frequency than seen in the British Isles panel
but not statistically signiﬁcant. Telomere length analysis in
four men showed that all were considerably longer in
sperm DNA, as expected (40). Interestingly, the 17 p telo-
mere, not the CI-HHV-6-associated telomere, was the
shortest we measured in the germline of all four sperm
donors. Moreover, the CI-HHV-6-associated telomere
was the longest measure in two of the sperm donors
(Table 1 and Supplementary Figure S4).
Examination of the telomere length distributions in
the sperm samples showed that a proportion of outlier mol-
ecules was considerably shorter than the mean length, as
reported previously (40). The shortened telomere molecules
likely arise through intra-telomere trimming via the t-loop
excision mechanism (7,41-43). We showed that the fre-
quency of short outlier molecules correlated with mean
telomere length in the germline. Consequently, the
longest CI-HHV-6-associated telomeres have the highest
frequency of outliers (Table 1 and Figure 3C), indicating
a high frequency of t-loop excisions within the telomere.
The HHV-6-associated 12q, 17 p and XpYp telomeres
shorten at similar rates in LCLs
The difference in the ranked length of the CI-HHV-6-
associated telomere between somatic cells and the
germline suggests that the presence of the viral genome
affects length regulation. Analysis of telomere shortening
rates in two LCLs (GM18999 CI-HHV-6A and
CEPH1375.02 CI-HHV-6B) showed similar attrition
rates (average 79 bp/cell division) at the Xp/Yp, 12q,
17 p and CI-HHV-6-associated telomere in both cell
lines (Supplementary Figure S5). This suggests that the
disparity between the length of the CI-HHV-6-associated
telomere in somatic cells and the germline is not explained
by a higher rate of telomere erosion at the virus-associated
telomere. However, we detected low-level telomerase
expression in the CEPH1375.02 CI-HHV-6B at all time
points and in some time points for the GM18999 CI-
HHV-6A cell line. Clearly, the level of telomerase is insuf-
ﬁcient to maintain telomere length in these cell lines but
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we cannot exclude the possibility that it may target one
telomere more than another.
Somatic truncation of the integrated HHV-6 genome and
viral excision
The detection of short telomere molecules in the germline
(Supplementary Figure S4 and Figure 3C) (40) prompted
us to look for extra-chromosomal circular molecules. We
detected extra-chromosomal circles containing (TTAGG
G)n repeats in the CEPH1375.02 LCL, which arise from
low-frequency intra-telomere t-loop excision at all telo-
meres (41–43). We also detected extra-chromosomal
circular molecules containing HHV-6 DR sequences
(Supplementary Figure S6). These may arise from
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Figure 2. Characterization of the viral DRs in CI-HHV-6 carriers. (A) Diagram summarizing the composition of DRR and DRL in CI-HHV-6A and
B carriers. The expected location of the cleavage and packaging sequences, PAC1 and 2, is shown. The terminal PAC1 and PAC2, which are absent
in CI-HHV-6 carriers, are identiﬁed (grey cross). The orientation of the DRs is shown by dashed arrows; plain arrows represent primers. (B)
Isolation of internal subtelomere-CI-HHV-6 junctions in one CI-HHV-6A carrier (HGDP00628) and three CI-HHV-6B carriers (HGDP01065,
HGDP01077, both Sardinians and 1-9p34.3) by PCR ampliﬁcation between a subtelomeric primer (SubT17-539) and a primer in DR8 (DR8F).
The subtelomere-CI-HHV-6 junctions in the other nine CI-HHV-6 samples analysed did not amplify with the SubT17-539 primer. (C)
Characterization of viral T1 and T2 telomere-like repeat regions and their associated PAC1 and PAC2 sequences. PCR ampliﬁcation across the
DRR-T1 region of degenerate telomere-like repeats using a primer anchored in the unique region (U100F2) with the DR1R primer in 13 CI-HHV-6B
and 2 CI-HHV-6A carriers shows that T1 is greatly expanded (particularly in CI-HHV-6B) and varies in length between carriers (top). The DRR-
PAC1 sequence is retained in all CI-HHV-6B carriers, as shown by secondary PCR using the PAC1RB primer (speciﬁc to HHV-6B PAC1) with the
U100F2 primer (second panel). The DRL-T2 region [pure (TTAGGG)n] shows the expected modest length variation between carriers, as
demonstrated by PCR with a primer anchored in the unique region, UDL6R, and DR8F (third panel). In addition, the DRL-PAC2 sequence is
retained in all carriers, as shown by secondary PCR using the PAC2F primer with UDL6R (bottom).
Nucleic Acids Research, 2013 7
ADR
1R 12
q
17
p
Xp
Yp
0
2500
5000
7500
10000
12500
Te
lo
m
er
e 
Le
ng
th
 (b
p)
10
6
3
1
2
Kb
0.5
1501 CI-HHV-6A
12q 17p XpYp DR1R
0 5 10 15 20
0
1000
8000
10000
12000
14000
16000
18000
D1-DR1R  
D1-12q  
D1-17p  
D1-XpYp  
D32-DR1R  
D32-12q  
D32-17p  
D32-XpYp  
D44-DR1R  
D44-12q  
D44-17p  
D44-XpYp  
D56-DR1R  
D56-12q  
D56-17p  
D56-XpYp  
Telomeres <3SD (%)
Te
lo
m
e
re
 
Le
ng
th
 
(bp
)
C
Shortest telomere 
in cell lines (16)
8
50%
3
19%
3.5
22%
1.5
9%
B
DR
1R 12
q
17
p
Xp
Yp
0.0
0.1
0.2
0.3
0.4
0.5
0.6
X p Y pD R 1R 1 2 q 1 7 p
Fr
eq
ue
nc
y 
of
 s
ho
rte
st
 te
lo
m
er
e
Shortest telomere 
in blood DNA (24)
10
42%
3
12%
4.5
19%
6.5
27%
Figure 3. Telomere length analysis in CI-HHV-6 carriers. (A) STELA was used to measure telomere length at 12q, 17 p, XpYp and on the end of the
virus (DR1R) in CI-HHV-6 carriers. It shows a representative STELA-Southern blot on blood DNA from one CI-HHV-6A carrier (1501) and below
the scatter plots of the data obtained from several blots. The median and inter-quartile ranges are shown as red lines. (B) The median values for each
of the four telomeres measured were ranked by length in DNAs from 16 LCLs and 24 blood DNAs from CI-HHV-6 carriers. The proportion of the
samples in which each telomere is the shortest is shown in pie charts for the LCLs and blood DNA samples. The histogram of the combined data
shows that the shortest telomere frequency (+SEM) is different between the chromosome ends (Kruskal–Wallis test P< 0.0117). (C) Relationship
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excision of a quasi t-loop formed by invasion of the
telomeric 30 single-strand overhang into the DRL-T2
(Figure 4A). The reciprocal product of excisions should
be a truncated CI-HHV-6 with a novel telomere at DRL-
T2. Therefore, we conducted STELA using a ﬂanking
primer at the U1 gene and detected very short telomere
molecules (140–200 bp) in ﬁve CI-HHV6B cell lines (two
shown in Figure 4B). Ampliﬁcation of the short telomere
molecules is dependent on the presence of a telomeric 30
single-strand overhang, as ExoI digestion before STELA
abolished the products. Sequence analysis showed these
amplicons contain DRL-PAC2.
We hypothesized that the entire viral genome could be
released from the telomere through telomeric 30 single-
strand overhang (eroded into the DRL-T1 region)
invasion into the internal DRR-T1 region or between a
viral genome already truncated at DRL-T2 into the
internal DRR-T2 (Figure 4A). Resolution of the quasi
t-loop, which would include the whole viral genome,
could release the HHV-6 genome as a large circular
molecule comprising the unique region and a single
reconstituted DR with both PAC1 and PAC2. Telomere
length analysis in the CEPH1375 family had shown that
the telomere on the distal end of CI-HHV-6B was particu-
larly short in the maternal grandfather, CEPH1375.11
(Figure 1F). In addition, truncated CI-HHV-6B molecules
with a short telomere at DRL-T2 were readily detected in
CEPH1375.11 suggesting frequent abnormal t-loop for-
mation and excision events in this carrier. Ampliﬁcation
of CEPH1375.11 genomic DNA with the viral primers,
UDL6R (in the U1 gene) and U100F2 (Figure 4A), that
point away from one another on the integrated virus
generated large products (16 kb) that were detected by
Southern blot hybridization to the viral DR3 or (TTAGG
G)n probe (Figure 4C). Characterization of these products
showed they include U1, PAC2, T2, DR8 to DR1, T1
(5 kb), PAC1 and U100 sequences (Figure 4D),
indicating they contain a reconstituted DR region with
both PAC1 and PAC2. The 16-kb amplicons generated
from CEPH1375.11 are not artifacts arising from
jumping-PCR, as no such amplicons were generated
from genomic DNA of other CI-HHV-6B carriers in the
CEPH1375 family (CEPH1375.02 shown) or from an
unrelated CI-HHV-6B carrier (6-17p13.3).
Integrated HHV-6B genome is intact in the
CEPH1375 family
If telomere integration is an effective form of latency (44),
then the viral genome should remain intact despite local-
ization adjacent to subtelomeric regions that have a rela-
tively high turnover rate (45). To investigate this in the
CEPH1375 family, we generated overlapping amplicons
from the HHV-6B unique region and DRs (without T1
and T2) from CEPH1375.02. All amplicons were the
expected sizes (Figure 4E). Similar analysis in a further
11 unrelated CI-HHV-6B carriers also showed that the
integrated viral genomes lacked any gross rearrangements.
The HHV-6B genome in CEPH1375.02 was sequenced
using ion semiconductor technology (37), with small
gaps closed using Sanger sequencing. This conﬁrmed
that the integrated HHV-6B genome in CEPH1375.02 is
intact and differs from the HHV-6B HST strain by 282
base substitutions and a few single base indels. In silico
analysis of the base substitutions and indels indicates that
none are predicted to cause disruptive frameshifts in the
ORFs (Supplementary Figure S6).
Spliced U90 transcripts detected in CI-HHV-6 carriers
Expression analysis of U38, U73, U90 and U94 in 10 dif-
ferent CI-HHV-6 LCLs consistently revealed transcripts
from the U90 gene in all 10 LCLs, whereas detection of
transcripts from other genes varied between the LCLs and
between RNA samples. Seven LCLs showed two different
length U90-reverse transcriptase PCR (RT-PCR)
products, two LCLs showed only the shorter product
and one LCL showed only the longer product. Sequence
analysis showed that the shorter product had undergone a
correct splicing to remove an intron (Figure 5). The HHV-
6 U90 gene is an immediate early transactivator that
produces different transcripts during productive infection
and latency owing to alternative splicing and the use of
alternative start sites (46). Detection of the spliced U90
transcripts is further evidence that CI-HHV-6 is a form
of latency.
DISCUSSION
Among the ﬁve internal CI-HHV-6 junction fragments we
isolated (2 CI-HHV-6A and 3 CI-HHV-6B carriers), four
were different, thus representing independent integration
events, and all shared a similar sequence organization
(25,47). The absence of DRR-PAC2 and the presence of
telomere sequence-variant repeats (3) in each junction
support the proposition that HHV-6 integrates by HR
between DRR-T2 and the proximal end of a telomere.
The absence of PAC1 at the terminal end of DRL could
also be a consequence of HR at the time of integration.
However, the curious expansion of the T1 region,
Table 1. Telomere length analysis in sperm DNA from CI-HHV-6
carriers
Donor and
telomere
Mean length±
SD (bp)
Total
number
of bands
Number
of outliers
Percentage
outliers
D1-DR1R 13 676±1950 385 28 7.3
D1-12q 14 428±4111 357 22 6.2
D1-17p 9996±1825 277 7 2.5
D1-XpYp 14 311±2931 259 15 5.8
D32-DR1R 16 625±2627 191 26 13.6
D32-12q 13 160±2970 261 13 5.0
D32-17p 8424±1719 256 4 1.6
D32-XpYp 13 803±1418 153 20 13.1
D44-DR1R 12 680±2172 255 24 9.4
D44-12q 11 304±3085 482 21 4.4
D44-17p 8259±1535 187 4 2.1
D44-XpYp 14 122±1210 141 17 12.1
D56-DR1R 16 018±1600 141 21 14.9
D56-12q 13 470±3569 358 26 7.3
D56-17p 9742±2427 243 4 1.6
D56-XpYp 14 825±1201 156 17 10.9
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identiﬁed through analysis of the internal DRR-T1, and
the variable truncation of the terminal DRL-T1 in carriers
suggest that the degenerate repeat region underwent
erosion. Therefore, the expanded T1 region may serve a
role during integration by acting as a buffer for replica-
tion-driven erosion that results in loss of PAC1 and part
of the DRL-T1 region until (TTAGGG)n repeats are
added by telomerase in the germline.
The CI-HHV-6-associated telomere was the shortest
measured in somatic cells from 45% of the 40 carriers
investigated but not the shortest in the four CI-HHV-6
sperm donors showing that the virus-associated telomere
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hybridization to a probe for DR3. (D) The amplicons generated from circular HHV-6 DNA molecules in CEPH1375.11 contain a single DR with
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genome is present in the CEPH1375 family. Overlapping amplicons (1–31) covering the unique portion of the HHV-6B genome and the DRs
(amplicon 32, without T1 and T2) were generated from CEPH1375.02. Each amplicon is the expected size showing there are no gross rearrangements
of the integrated viral genome.
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is readily lengthened by telomerase in the germline. The
disparity between CI-HHV-6-associated telomere length
in somatic cells and the germline suggests that the
integrated virus perturbs an aspect of telomere function.
We showed that the rate of telomere erosion through rep-
lication-driven processes was not higher at the CI-HHV-6-
associated telomere in LCLs from two CI-HHV-6 carriers.
However, as these cell lines showed a low level of telomer-
ase activity, further analysis will be required to determine
whether or not telomerase is targeted to the CI-HHV-6
telomere more frequently.
We surmised that the presence of the HHV-6 genome
might interfere with telomere capping by perturbing of
t-loop formation and excision giving rise to telomere
rapid deletion events that were ﬁrst described in yeast
(48,49). We showed that LCLs from CI-HHV-6B
carriers are mixed populations of cells carrying the full-
length CI-HHV-6B and a subset with CI-HHV-6B
chromosomes truncated at DRL-T2 by the presence of a
novel very short telomere with a single-strand overhang
(Figure 4). The truncations at DRL-T2 could arise
through a double-strand break at DRL-T2, followed by
end processing to generate a 30 single-strand overhang.
However, as we also detected extra-chromosomal
circular molecules containing HHV-6 DR sequences, we
favour a model in which the truncated chromosomes arise
through processing of a t-loop (41–43) formed by strand
invasion of the telomeric 30 single-strand overhang within
DRL-T2. Excision of the quasi t-loop would result in a
sudden truncation and formation of a telomere at DRL-
T2. The presence of the novel short telomere may contrib-
ute to cell cycle arrest and the onset of senescence.
Sequence analysis of the CI-HHV-6B genome in the
CEPH1375.02 showed that the viral genome is intact in
this family; moreover, we detected molecules that contain
a reconstituted DR region with both PAC1 and PAC2 in
the grandfather CEPH1375.11. The reconstituted DR
region could only arise from a recombination event
between the terminal DRL (that contains a full-length
T2 and PAC2) and the internal DRR (that contains a
full-length T1 and PAC1) resulting in the release of
a circular molecule containing the viral genome with a
single DR (Figure 4). Therefore, consistent with our
model invoking t-loop formation including the viral
genome, we propose that occasional single-strand
invasion of the telomeric 30 overhang into the internal
HHV-6 DRR-T1 facilitates release of the entire viral
genome from the chromosome with a single reconstituted
DR (Figure 4A). These large extra-chromosomal circular
molecules arise from an intact viral genome (as shown by
the next-generation sequence analysis), and so they have
the potential to undergo rolling circle replication that
could regenerate full-length HHV-6B genomes with two
identical terminal DRs. This and the evidence that spliced
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Figure 5. Detection of viral transcripts from CI-HHV-6. (A) RT-PCR was used to detect transcripts from U38, U73, U90 and U94 in LCLs from
two CI-HHV-6A and eight CI-HHV6B carriers. Two different U90-RT-PCR products were visible in RNA samples from seven LCLs (e.g.
CEPH1375.11 and HapMapNA18999). These products were of the expected sizes for unspliced and spliced transcripts. (B) Sequence analysis of
the shorter U90 RT-PCR product showed that the intron (110 bp in italics) between exons 4 and 5 (44) was absent conﬁrming that the U90 RNA
had undergone correct splicing. Black arrows show the positions of the U90B2F and U90B2R primers.
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transcripts from the U90 gene, which is involved in
latency, were detected in the cell lines investigated
support the hypothesis that CI-HHV-6 is an alternative
form of viral latency.
The reciprocal product of a large excision event would
be retention of a DR, lacking both PAC sequences,
within the telomere. Interestingly, we have identiﬁed two
unrelated individuals (2/3859; population frequency
0.05%) that lack the unique portion of the HHV-6B
genome but carry a single HHV-6B-DR (without PAC1
and 2) integrated into a telomere. These individuals may
have inherited chromosomes that had already undergone a
viral excision event, although partial insertion during in-
tegration cannot be excluded. The released viral genome
with a single reconstituted DR in CEPH1375.11 could also
arise by strand invasion of a short telomere on a CI-HHV-
6 molecule already truncated at DRL-T2. Excision would
release a circular HHV-6 genome with a reconstituted
DR and remove the viral genome from the telomere
(Figure 4A [3]).
In summary, we have shown that the CI-HHV-6-
associated telomere is often one of the shortest in
somatic cells and prone to sudden deletions that create a
critically short telomere at a new location in the viral
genome. The presence of a short telomere associated
with the CI-HHV-6 will increase the chance that the cell
will become senescent, thus affecting tissue homeostasis
(9,10). Moreover, cells carrying critically short telomeres
associated with CI-HHV-6 may be prone to telomere
fusion events that can drive instability. We also show
that integrated copies of HHV-6B can be excised from
the chromosome and we propose that this is achieved
through use of the t-loop excision mechanism. This may
facilitate spreading to another telomere within the cell or
represent the ﬁrst step towards viral reactivation.
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